Lopinavir Dosing in HIV-infected Children in the United Kingdom and Ireland

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  2013-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/INF.0b013e31827842c9PMID 23076384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Response to planned treatment interruptions in HIV infection varies across childhood

  2010cited by this paper
• Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results

  2008cited by this paper
• Pharmacokinetics of Lopinavir in HIV Type-1-Infected Children Taking the New Tablet Formulation Once Daily

  2008cited by this paper
• Plasma Concentrations of the HIV-Protease Inhibitor Lopinavir are Suboptimal in Children Aged 2 Years and Below

  2007cited by this paper
• Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.

  2007cited by this paper
• Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study

  2006cited by this paper
• Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland

  2003cited by this paper
• Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

  2003influential reference
• PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV‐1 infection

  2002cited by this paper
• Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions.

  1994cited by this paper

• Evolution of Penicillin Non-susceptibility Among Streptococcus pneumoniae Isolates Recovered From Asymptomatic Carriage and Invasive Disease Over 25 years in Brazil, 1990–2014

  2019cites this paper
• Designing ecologically-optimised vaccines using population genomics

  2019cites this paper
• Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV

  2019cites this paper
• Comparison of early effects of PCV7, PCV10 and PCV13 on S. pneumoniae (SP) nasopharyngeal carriage in a population based study; the Palestinian-Israeli Collaborative Research (PICR)

  2018cites this paper
• Assessing the efficiency of catch-up campaigns for introduction of pneumococcal conjugate vaccine; a modelling study based on data from Kilifi, Kenya

  2017cites this paper
• Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective

  2016cites this paper
• Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden

  2016cites this paper
• Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination

  2015cites this paper
• Noninvasive Streptococcus pneumoniae Serotypes Recovered from Hospitalized Adult Patients in the United States in 2009 to 2012

  2015cites this paper
• Radical serotype rearrangement of carried pneumococci in the first 3 years after intensive vaccination started in Hungary

  2015cites this paper
• Characterization of Streptococcus pneumoniae clones from paediatric patients with cystic fibrosis.

  2014cites this paper
• Determinants of Highly Active Antiretroviral Therapy Duration in HIV-1-Infected Children and Adolescents in Madrid, Spain, from 1996 to 2012

  2014cites this paper
• Decreased Ceftriaxone Susceptibility in Emerging (35B and 6C) and Persisting (19A) Streptococcus pneumoniae Serotypes in the United States, 2011-2012: Ceftaroline Remains Active In Vitro among β-Lactam Agents

  2014cites this paper
• Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective

  2013cites this paper
• Pneumococcal Carriage in Young Children One Year after Introduction of the 13-Valent Conjugate Vaccine in Italy

  2013cites this paper
• Five-year prospective study of paediatric acute otitis media in Rochester, NY: modelling analysis of the risk of pneumococcal colonization in the nasopharynx and infection

  2013cites this paper